Novavax, Inc. (NASDAQ: NVAX) is having yet another incredible day in the market today, and for good reason. Today is the day of a key update that investors have been waiting for. Of course, the excitement continues to build after the stock climbed around 50% since July 17th. As is almost always the case, our partners at Trade Ideas were the first to alert us to the gains. At the moment (10:44), NVAX is trading at $1.72 per share after a gain of $0.24 (16.22%) thus far today.
NVAX Climbs Ahead Of Update
As mentioned above, Novavax is having an incredible day in the market today as we get closer and closer to a very important conference call. The rally started on July 17th, after the company announced that it would be hosting a conference call and webcast today. The call will be held at 4:30 ET and the information to get involved is below.
This particular call surrounds topline data from a recent Phase 2 Safety and immunogenicty trial of the RSV-F vaccine the company has been working on for adults 60 years of age and older. NVAX also said that it will be providing updated information with regard to prior Phase 2 and Phase 3 clinical trials in older adults and its RSV Phase 3 clinical trial for infants via maternal immunization. Here is the agenda for the webcast:
- First NVAX will announce topline data from the Phase 2 safety and immunogenicity trial in older adults.
- The company then intends to provide additional findings associated with previous Phase 2 and Phase 3 clinical trials in older adults.
- Finally, NVAX will provide an update on the Prepare(TM) clinical trial for infants via maternal immunization.
If you’d like to take part in the study, you can do so by either calling in or clicking at 4:30 ET tonight. Here’s the information:
- Call In – If you plan on calling into the Novavax presentation, you can do so by calling (877) 212-6076 if you’re in the United States or calling (707) 287-9331 if you are not. The passcode for the call is 54820069.
- On The Web – You can also log into the webinar by going to www.novavax.com.
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will be keeping a close eye on NVAX. In particular, we’ll be listening to the presentation later today, and we are overwhelmingly excited to learn more about the data. We’ll continue to follow the story closely and bring the news to you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!